Cannabinoids and pain

Pain Research and Management

Volumn 6, Issue 2, 2001, Pages 74-79

  Walker, J M ^a   Strangman, N M ^a   Huang, S M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Analgesia; Anandamide; Cannabinoid; Endocannabinoid; Pain; Receptor

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; AJULEMIC ACID; ANANDAMIDE; APOMORPHINE; ARACHIDONYLETHANOLAMINE; ARACHIDONYLGLYCEROL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABIS; CODEINE; DRONABINOL; ENDOCANNABINOID; FREUND ADJUVANT; LEVODOPA; LEVONANTRADOL; LIGAND; NABILONE; OPIATE DERIVATIVE; PSYCHOTROPIC AGENT; RIMONABANT; UNCLASSIFIED DRUG;

ANALGESIA; BRAIN DEPTH STIMULATION; CANCER PAIN; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE MODEL; DOSE RESPONSE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG USE; DYSPHORIA; ELECTROSTIMULATION; HUMAN; INHIBITION KINETICS; MOLECULAR DYNAMICS; MOTOR SYSTEM; NERVOUS SYSTEM; NEUROBIOLOGY; NEUROTRANSMISSION; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; SPINAL CORD NERVE CELL; THALAMUS;

EID: 0034891711     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/413641     Document Type: Conference Paper

References (61)

1. The pharmacology of cannabis
2. Pharmacological effects of two active constituents of marihuana
3. Antipyretic analgesic and anti-inflammatory effects of delta 9-tetrahydrocannabinol in the rat
4. 9-tetrahydrocannabinol in the rat and mouse
5. 9-nor-9β-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: Comparisons with morphine
6. Spinal and supraspinal components of cannabinoid-induced antinociception
7. 2-noradrenergic mechanism
8. The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat
9. 9-tetrahydrocannabinol THC
10. Analgesic and antiinflammatory activity of constituents of Cannabis sativa L.
11. A pharmacological analysis of levonantradol antinociception in mice
12. Suppression of noxious stimulus-evoked expression of fos-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist
13. The analgesic effects of R(+)-WIN 55,212-2 mesylate a high affinity cannabinoid agonist, in a rat model of neuropathic pain
14. Determination and characterization of a cannabinoid receptor in rat brain
15. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
16. Molecular characterization of a peripheral receptor for cannabinoids
17. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
18. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
19. Immunohistochemical localization of cannabinoid CB1 receptors in rat central nervous system
20. The effects of cannabinoids on the brain
21. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
22. Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system
23. Anandamide an endogenous cannabinoid inhibits calcium currents as a partial agonist in N18 neuroblastoma cells
24. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model
25. Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment
26. Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord
27. Cannabinoid receptors undergo axonal flow in sensory nerves
28. CB1 receptor localization in spinal cord and roots, dorsal root ganglion, and peripheral nerve
29. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
30. Identification of an endogenous 2-monoglyceride, present in canine gut that binds to cannabinoid receptors
31. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
32. A novel neurotransmitter system involved in the control of motor behavior by the basal ganglia
33. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2
34. Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2
35. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neuron in the lumbar dorsal horn of the rat
36. Intrathecal cannabinoid administration suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in rat spinal cord: Comparison with morphine
37. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by the cannabinoid WIN 55,212-2: Correlation between electrophysiological and antinociceptive effects
38. The cannabinoid WIN 55, 212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses
39. Antinociceptive actions of WIN 55,212-2 following intraventricular administration in rats
40. An examination of the central sites of action of cannabinoid-induced antinociception in the rat
41. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections
42. Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla
43. Pharmacologic evidence for the modulation of nociception by noradrenergic neurons
44. An analgesia circuit activated by cannabinoids
45. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity
46. SR141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice
47. Antihyperalgesic effects of spinal cannabinoids
48. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia
49. Pain modulation by release of the endogenous cannabinoid anandamide
50. Antinociceptive activity of intrathecally administered cannabinoids alone and in combination with morphine in mice
51. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
52. Control of pain initiation by endogenous cannabinoids
53. Analgesic effect of delta-9-tetrahydrocannabinol
54. The analgesic properties of delta-9-tetrahydrocannabinol and codeine
55. Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response
56. Analgesic effects of 1′,1′dimethylheptyl-delta8-THC-11-oic acid (CT3) in mice
57. Cannabinol derivatives: Binding to cannabinoid receptors and inhibition of adenylylcyclase
58. Cannabis and endogenous cannabinoid systems
59. Anandamide amidohydrolase (fatty acid amide hydrolase)